Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51
In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in gene therapy, and why AI has become essential in designing safer, more effective treatments. TPM E51 highlights >Episode 51 links:Michelle Chen on LinkedInForm Bio
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Talking Precision Medicine
Kamal Jethwani | The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56
Shakti Ramkissoon | The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55
Sean Khozin | The rhythm and dissonance of cancer biology | TPM podcast #54
Colette Delawalla | Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53
Get summaries like this every morning.
Free AI-powered recaps of Talking Precision Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.